Statistics from Altmetric.com
Delegates from the 35 member countries of the European Association of Hospital Pharmacists (EAHP) came together on 11 and 12 June for the 51st General Assembly. Because of the COVID-19 pandemic this gathering was virtual.
During the General Assembly, delegates received updates on EAHP’s educational activities, the core projects of the Association and current policy developments. Discussions centred on the implementation of the 44 European Statements of Hospital Pharmacy, the Common Training Framework for hospital pharmacy specialisation, access to medicines and the growing problem of medicines shortages, in particular those linked to immunoglobulins that are increasingly impacting patient care.
At the end of the General Assembly, András Süle was welcomed as EAHP’s new President. For the next 3 years, he will be steering the Association. Dr András Süle is currently the Chief Pharmacist at Péterfy Hospital and Trauma Centre as well as the Chief Pharmacy Advisor at Duna Medical Centre, both located in Hungary. He is a guest lecturer and lead developer of the Hospital Pharmacy Specialisation programme at Semmelweis University in Budapest. In 2008, he obtained a PhD from Semmelweis University and has since gone on to complete a PharmD Specialisation in Pharmaceutical Technology and a PharmD Specialisation in Clinical Pharmacy.
Reflecting on the goals for this 3 year presidency, Dr András Süle outlined the following: “I feel very honoured to take over EAHP’s primary leadership role from Petr Horák and his predecessors who have done a great job in improving patient care and advancing the hospital pharmacy profession in the almost 50 years that our Association now exists. I will have some very big shoes to fill, especially since I am taking over as EAHP’s President during a global pandemic. However, knowing our profession has gone above and beyond during this unprecedented time, I also feel confident that …
Competing interests None declared.
Provenance and peer review Commissioned; internally peer reviewed.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.